Fransa - İngilizce - HMA (Heads of Medicines Agencies)

novartis sa - ciclosporin 50 mg - capsule, soft - dogs - ciclosporin

İtalya - İngilizce - HMA (Heads of Medicines Agencies)

novartis sa - ciclosporin 50 mg - capsule, soft - dogs - ciclosporin

Hollanda - İngilizce - HMA (Heads of Medicines Agencies)

novartis sa - ciclosporin 50 mg - capsule, soft - dogs - ciclosporin

Portekiz - İngilizce - HMA (Heads of Medicines Agencies)

novartis sa - ciclosporin 50 mg - capsule, soft - dogs - ciclosporin

Birleşik Krallık - İngilizce - HMA (Heads of Medicines Agencies)

novartis sa - ciclosporin 50 mg - capsule, soft - dogs - ciclosporin

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 100 mg - capsule, soft - excipient ingredients: propylene glycol; iron oxide black; titanium dioxide; corn glycerides; dl-alpha-tocopherol; glycerol; gelatin; ethanol; peg-40 hydrogenated castor oil; hypromellose; purified water; isopropyl alcohol; cochineal; aluminium chloride; sodium hydroxide - cyclosporin sandoz is indicated as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. for induction and/or maintenance of remission in the nephrotic syndrome. cyclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see precautions). for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with the quality of life. for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate. careful monitoring of all cyclosporin-treated patients is mandatory. cyclosporin should only be used by medical practitioners who are experienced in the use of immunosuppressive therapy (see "precautions").

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 25 mg - capsule, soft - excipient ingredients: titanium dioxide; peg-40 hydrogenated castor oil; propylene glycol; glycerol; corn glycerides; iron oxide black; dl-alpha-tocopherol; gelatin; ethanol; hypromellose; purified water; isopropyl alcohol; cochineal; aluminium chloride; sodium hydroxide - cyclosporin sandoz is indicated as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. for induction and/or maintenance of remission in the nephrotic syndrome. cyclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see precautions). for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with the quality of life. for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate. careful monitoring of all cyclosporin-treated patients is mandatory. cyclosporin should only be used by medical practitioners who are experienced in the use of immunosuppressive therapy (see "precautions").

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

dexcel pharma gmbh - ciclosporin - capsule, soft - 50 milligram(s) - calcineurin inhibitors; ciclosporin

Malta - İngilizce - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - ciclosporin - concentrate for solution for infusion - ciclosporin 50 mg/ml - immunosuppressants

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

sun pharma japan limited - ciclosporin - yellowish white capsule, major axis: 18.1 mm, minor axis: 6.4 mm